AlphaStocks
5.4
Consider Buy

Healthstream Inc (HSTM)

As of Sep 20, 2026, Healthstream Inc (HSTM) scores 5.4/10 on AlphaStocks' five-model composite, #80 of 168 Health Care stocks. At $29, HSTM trades 109% above its model fair value of $14.

Health Care / Health Care Technology

S&P SmallCap 600

$29.20

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#80out of 168 in Health Care

Is HEALTHSTREAM INC a Good Investment in 2026?

HEALTHSTREAM INC (HSTM) scores 5.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates HEALTHSTREAM INC as Attractive (5/9). However, the Graham model rates it Caution — Significantly above fair value. HEALTHSTREAM INC currently trades 109% above its estimated fair value of $14. HEALTHSTREAM INC ranks #80 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E48.0ROE5.2Market Cap859.0M

Estimated Fair Value

$13.97109% above

Trading above estimated fair value. P/e of 48x implies high growth expectations. eps growth of -7% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Attractive

High PEG — growth premium · Slow Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is HEALTHSTREAM INC (HSTM) a good investment?
As of Sep 20, 2026, Healthstream Inc (HSTM) scores 5.4/10 on AlphaStocks' five-model composite, #80 of 168 Health Care stocks. At $29, HSTM trades 109% above its model fair value of $14. That score is below average, suggesting caution.
What is HEALTHSTREAM INC's Piotroski F-Score?
HEALTHSTREAM INC's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HSTM overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $14, HSTM appears overvalued. The stock currently trades 109% above its estimated fair value. Trading above estimated fair value. P/e of 48x implies high growth expectations. eps growth of -7% may not justify the premium.
How does HSTM compare to other Health Care stocks?
HEALTHSTREAM INC ranks #80 out of 168 stocks in the Health Care sector, placing it in the top 48% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about HSTM?
AlphaStocks evaluates HSTM using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Attractive. These models are combined into a single composite score of 5.4/10.

Similar Stocks

SOLVVEEVCERT

Compare HSTM with

HSTM vs SOLVHSTM vs VEEVCERT vs HSTM

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer